Trade Summary

6 days ago, Cohlhepp Ryan, serving as Pres, COO at Bicara Therapeutics Inc. (BCAX), sold 12,500 shares at $20.29 per share, for a total transaction value of $253,649.00. Following this transaction, Cohlhepp Ryan now holds 191,641 shares of BCAX.

This sale represents a 6.00% decrease in Cohlhepp Ryan's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, May 15, 2026 and publicly disclosed via SEC Form 4 filing on Monday, May 18, 2026 at 4:24 PM ET, 3 days after the trade was made.

Bicara Therapeutics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.